zeneca zd 6169 has been researched along with cifenline in 1 studies
| Studies (zeneca zd 6169) | Trials (zeneca zd 6169) | Recent Studies (post-2010) (zeneca zd 6169) | Studies (cifenline) | Trials (cifenline) | Recent Studies (post-2010) (cifenline) |
|---|---|---|---|---|---|
| 42 | 0 | 3 | 303 | 49 | 33 |
| Protein | Taxonomy | zeneca zd 6169 (IC50) | cifenline (IC50) |
|---|---|---|---|
| Sodium channel protein type 1 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 4 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 7 subunit alpha | Homo sapiens (human) | 7.8 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 8.8 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 9 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 2 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 3 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 11 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 8 subunit alpha | Homo sapiens (human) | 7.8 | |
| Sodium channel protein type 10 subunit alpha | Homo sapiens (human) | 7.8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brading, AF; Ito, Y; Masaki, I; Sueishi, K; Takano, M; Teramoto, N; Yonemitsu, Y; Yunoki, T | 1 |
1 other study(ies) available for zeneca zd 6169 and cifenline
| Article | Year |
|---|---|
Dual action of ZD6169, a novel K(+) channel opener, on ATP-sensitive K(+) channels in pig urethral myocytes.
Topics: Adenosine Triphosphate; Amides; Animals; Anti-Arrhythmia Agents; Benzophenones; Cells, Cultured; COS Cells; Cromakalim; Electric Conductivity; Female; Glyburide; Hypoglycemic Agents; Imidazoles; Ion Channel Gating; Membrane Potentials; Muscle, Smooth; Patch-Clamp Techniques; Potassium Channels; Potassium Channels, Inwardly Rectifying; Swine; Time Factors; Urethra; Vasodilator Agents | 2001 |